Kaycide-T 1125 Injection
Marketer
Stenkem Molecules Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Kaycide-T 1125 Injection
Kaycide-T 1125 Injection, a multi-component medication, combats diverse bacterial infections. Its action inhibits microbial proliferation and halts infection progression. Administration must be overseen by a healthcare provider; strict adherence to the prescribed schedule is crucial. Complete the entire treatment course, regardless of symptom improvement; premature cessation may compromise efficacy. Nausea, vomiting, diarrhea, and dyspepsia are potential side effects; worsening symptoms necessitate immediate medical attention. Seek immediate help for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all current medications before commencing treatment; this is especially important for pregnant or lactating individuals. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are recommended to facilitate recovery. Monitoring treatment efficacy may involve prescribed laboratory tests and diagnostic procedures.
Primary Ingredients of Kaycide-T 1125 Injection
The provided text is "undefined," therefore, no rephrasing is possible.
Uses of Kaycide-T 1125 Injection
Infections caused by bacteria
Major Benefits of Kaycide-T 1125 Injection:
Administering this medication requires the expertise of your doctor or nurse; please do not attempt self-medication.
Common Side effects of Kaycide-T 1125 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Kaycide-T 1125 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Kaycide-T 1125 Injection works:
Ceftriaxone and Tazobactum, the active components of Kaycide-T 1125 Injection, act synergistically. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus boosting Ceftriaxone's efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of Kaycide-T 1125 Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Kaycide-T 1125 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, data from human trials remain scarce.
Breast feedingCAUTION
The administration of Kaycide-T 1125 Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Kaycide-T 1125 Injection might induce drowsiness, visual impairment, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Kaycide-T 1125 Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Kaycide-T 1125 Injection requires careful administration in individuals with advanced hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Kaycide-T 1125 Injection is unnecessary in patients exhibiting mild or moderate hepatic dysfunction.
What if you forget to take Kaycide-T 1125 Injection :
Omit a Kaycide-T 1125 Injection dose? Seek medical advice immediately.
Facts to Know About Kaycide-T 1125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |
3,018 People bought this recently